Reviva Pharmaceuticals Holdings, Inc.
RVPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001742927
No open-market purchases or sales by Reviva Pharmaceuticals Holdings, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $3.67K in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Reviva Pharmaceuticals Holdings, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +4 vs. Q1 2024
- Shares held
- 6.85M
- +1.28M (+23.0%) vs. Q1 2024
- Total value
- $8.75M
- −$12.3M (−58.3%) vs. Q1 2024
- New holders
- 9
- 12 more added
- Sold out
- 5
- 4 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $3.67K |
| Q1 2026 | 35 | $2.13M |
| Q4 2025 | 48 | $3.17M |
| Q3 2025 | 42 | $3.52M |
| Q2 2025 | 46 | $5.44M |
| Q1 2025 | 49 | $6.95M |
| Q4 2024 | 42 | $14.0M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 31 | $8.75M |
| Q1 2024 | 28 | $21.0M |
| Q4 2023 | 36 | $27.1M |
| Q3 2023 | 24 | $13.0M |
| Q2 2023 | 23 | $15.5M |
| Q1 2023 | 22 | $5.76M |
| Q4 2022 | 23 | $5.54M |
| Q3 2022 | 19 | $1.65M |
| Q2 2022 | 13 | $2.05M |
| Q1 2022 | 16 | $4.68M |
| Q4 2021 | 14 | $7.54M |
| Q3 2021 | 12 | $10.5M |
| Q2 2021 | 12 | $12.8M |
| Q1 2021 | 8 | $3.37M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Reviva Pharmaceuticals Holdings, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Woodline Partners LP | 1,592,788 | $2.04M | 0.02% | +537,779+51.0% | Added |
| Millennium Management LLC | 1,241,493 | $1.59M | 0.00% | +386,896+45.3% | Added |
| Vanguard Group Inc | 1,025,249 | $1.31M | 0.00% | +23,413+2.3% | Added |
| Schonfeld Strategic Advisors LLC | 1,013,791 | $1.30M | 0.01% | +187,191+22.6% | Added |
| Parkman Healthcare Partners LLC | 504,600 | $645.9K | 0.09% | +746+0.1% | Added |
| Sabby Management, LLC | 236,997 | $303.4K | 4.03% | +236,997 | New |
| Geode Capital Management, LLC | 236,120 | $302.3K | 0.00% | +16,003+7.3% | Added |
| Colony Group, LLC | 161,000 | $206.0K | 0.00% | −10,000−5.8% | Reduced |
| Polar Asset Management Partners Inc. | 154,800 | $198.1K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 132,440 | $169.5K | 0.00% | +124,341+1,535.3% | Added |
| EMC Capital Management | 123,915 | $140.0K | 0.08% | 00.0% | Unchanged |
| BlackRock Inc. | 102,932 | $131.8K | 0.00% | +11,071+12.1% | Added |
| State Street Corp | 71,400 | $91.4K | 0.00% | +8,200+13.0% | Added |
| Northern Trust Corp | 57,747 | $73.9K | 0.00% | +7,299+14.5% | Added |
| Susquehanna International Group, LLP | 41,012 | $52.5K | 0.00% | −201,655−83.1% | Reduced |
| Two Sigma Investments, LP | 31,068 | $39.8K | 0.00% | +31,068 | New |
| Sound Income Strategies, LLC | 30,000 | $38.4K | 0.00% | +30,000 | New |
| Group One Trading, L.P. | 29,392 | $37.6K | 0.00% | +29,392 | New |
| Morgan Stanley | 17,926 | $22.9K | 0.00% | +12,305+218.9% | Added |
| NRI Wealth Management LC | 12,380 | $15.8K | 0.01% | 00.0% | Unchanged |
| BluePointe Capital Management, LLC | 10,378 | $13.3K | 0.01% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 9,299 | $11.9K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 4,530 | $5.80K | 0.00% | +1,155+34.2% | Added |
| Bank of America Corp | 3,945 | $5.05K | 0.00% | −17,984−82.0% | Reduced |
| Simplex Trading, LLC | 2,420 | $3.00K | 0.00% | +2,420 | New |
| Activest Wealth Management | 1,000 | $1.28K | 0.00% | +1,000 | New |
| Archer Investment Corp | 500 | $640 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 390 | $499 | 0.00% | +390 | New |
| Advisor Group Holdings, Inc. | 125 | $160 | 0.00% | +125 | New |
| Qube Research & Technologies Ltd | 50 | $64 | 0.00% | −21,463−99.8% | Reduced |
| Royal Bank of Canada | 235 | $0 | 0.00% | +235 | New |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −38,663−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −34,868−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −30,090−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −175−100.0% | Sold out |
| Cutler Group LP | – | – | – | – | Not filed |